|Articles|September 21, 2022
Operational Impact of Annex 1 Update (Sept 2022)
Author(s)Veltek Associates, Inc.
The update for EU annex 1 is more than a simple revision, solidifying the expectation that facility fully understand their processes and systems.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
US Withdrawal From WHO Creates New Pharma Logistics Vulnerabilities
2
Securing Radiopharma and GLP-1 Supply Chains Through 2026 M&A
3
Lilly Invests $3.5B in Pennsylvania Injectable Medicine Facility
4
Halo Pharma Becomes Dedicated North American Drug Product CDMO
5